These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction. Meyer MF; Lieps D; Schatz H; Pfohl M Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131 [TBL] [Abstract][Full Text] [Related]
10. Methodological issues in the assessment of skin microvascular endothelial function in humans. Cracowski JL; Minson CT; Salvat-Melis M; Halliwill JR Trends Pharmacol Sci; 2006 Sep; 27(9):503-8. PubMed ID: 16876881 [TBL] [Abstract][Full Text] [Related]
11. Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover? Cutolo M; Sulli A; Smith V Expert Rev Clin Immunol; 2011 Jul; 7(4):395-7. PubMed ID: 21790279 [No Abstract] [Full Text] [Related]
14. The micro-circulation in systemic sclerosis. Jayson MI Clin Exp Rheumatol; 1984; 2(1):85-91. PubMed ID: 6398169 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis. Sunderkötter C; Riemekasten G Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii33-5. PubMed ID: 16987831 [TBL] [Abstract][Full Text] [Related]
16. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress. Iwata Y; Ogawa F; Komura K; Muroi E; Hara T; Shimizu K; Hasegawa M; Fujimoto M; Tomita Y; Sato S Rheumatology (Oxford); 2007 May; 46(5):790-5. PubMed ID: 17309887 [TBL] [Abstract][Full Text] [Related]
17. Difficulty in detecting reperfusion injury increment in oxidative stress among patients with primary Raynaud's phenomenon and systemic sclerosis. Herrick AL; Rieley F; Braganza JM; Jayson MI J Rheumatol; 1995 Feb; 22(2):374-5. PubMed ID: 7738971 [No Abstract] [Full Text] [Related]
18. [Determination of muscle microcirculation in the extremities of normal subjects and patients with scleroderma using 133Xenon-clearance. 2. Study of patients with progressive scleroderma]. Pönitzsch I; Wiemers U; Haustein UF; Schneider G Radiobiol Radiother (Berl); 1984; 25(2):349-53. PubMed ID: 6739777 [No Abstract] [Full Text] [Related]
19. Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjects. Dohi Y; Takase H; Sato K; Ueda R Int J Cardiol; 2007 Jan; 115(1):63-6. PubMed ID: 16759717 [TBL] [Abstract][Full Text] [Related]
20. [Microcirculatory disorders in the skin in systemic scleroderma]. Akhnazarova VD; Balabanova RM Ter Arkh; 1979; 51(6):77-81. PubMed ID: 473057 [No Abstract] [Full Text] [Related] [Next] [New Search]